PsychPlus Amarillo Clinic - Psychiatrist and Therapist
121 Westgate Parkway W, 40, Amarillo
4.2(33 Google reviews)
United States
2 listed treatment centers serving Amarillo and the surrounding area.
121 Westgate Parkway W, 40, Amarillo
4.2(33 Google reviews)
For people in Amarillo, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the prescribed visit schedule. Both the medication and the visit for supervised administration and monitoring may be billed. Ask for an estimate that includes all expected charges, rather than the medication alone.
Prior authorization is common. Your insurer may require records of earlier antidepressant trials, including which medicines you took, how long you took them, and your response. Ask the treatment center who gathers these records, submits the request, and follows up if the insurer needs more information. Authorization does not necessarily mean every charge will be paid.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. The two Amarillo entries in this directory are marked as not accepting Medicare or Medicaid; confirm current participation directly before scheduling. Those listings do not establish whether your benefits cover treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules, enrollment requirements, and which charges assistance may address.
Before starting Spravato, ask the center and your insurer:
Request written benefit information and keep copies of authorization decisions.
SPRAVATO® requires repeated trips to a REMS-certified healthcare setting. You administer the nasal spray yourself under direct observation by a healthcare provider; it is never taken home. This directory lists two Amarillo locations offering Spravato, but their REMS certification is not confirmed in the listing data. Verify certification and current appointment availability directly before making plans.
A typical labeled treatment-resistant depression schedule starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule for your situation; do not assume a fixed personal timetable.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. The overall appointment can take longer. If you work, ask about appointment hours and arrange enough time away for both treatment and travel. Avoid scheduling driving or machinery-related duties afterward.
Arrange for someone else to take you home after every session. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its pickup rules before relying on a taxi or rideshare, and consider a backup driver in case your usual ride cancels.
If no Amarillo center remains listed, or the listed options cannot accommodate you, other Texas cities with directory listings include Austin, Houston, San Antonio, Friendswood, Dallas, Fort Worth, McKinney, and El Paso. These are not necessarily nearby or practical alternatives. Confirm certification, availability, insurance participation, and a workable return-ride plan before committing to repeated travel.
This directory lists two Amarillo locations offering SPRAVATO®, but the available listing data do not confirm REMS certification. Contact each location to verify that it is currently certified, accepting patients, and providing treatment at the location you would attend. A directory listing alone is not proof of certification. Also ask about appointment availability and how the initial evaluation is arranged.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal thoughts or behavior. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks to determine whether it is appropriate; meeting an indication does not guarantee treatment.
Coverage depends on your plan and treatment setting. Prior authorization and records of earlier antidepressant trials are commonly required. Ask about coverage for both the medication and the supervised monitoring visit. The two Amarillo listings are marked as not accepting Medicare or Medicaid, so verify current participation directly. Medicare and Texas Medicaid may cover treatment in some circumstances, but coverage and a center’s willingness to accept that coverage are separate questions.
You self-administer the nasal spray under direct observation at a REMS-certified healthcare setting. Staff monitor you for at least two hours after dosing, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow extra time for preparation and discharge assessment. You cannot take the medicine home. Arrange someone else to drive you home, and do not drive until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your health history, medicines, and substance use openly with the clinician, and tell staff promptly about symptoms during monitoring.
No. If you are in crisis, call or text 988; if there is immediate danger or a medical emergency, call 911. Do not wait for a directory response or treatment appointment. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior. Even when prescribed for depressive symptoms associated with an acute suicidal crisis, it does not replace hospitalization when clinically needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.